Details
| Titel in Übersetzung | Ethical and legal issues when dealing with genetic incidental findings-challenges and possible solutions |
|---|---|
| Originalsprache | Deutsch |
| Seiten (von - bis) | 105-119 |
| Seitenumfang | 15 |
| Fachzeitschrift | Ethik in der Medizin |
| Jahrgang | 26 |
| Ausgabenummer | 2 |
| Frühes Online-Datum | 8 Feb. 2013 |
| Publikationsstatus | Veröffentlicht - Juni 2014 |
Abstract
Definition of the problem With an increasing number of genetic results obtained in whole genome analyses, the problem of incidental findings arises, i.e., findings that are discovered beyond the aims of the original investigation but have potential health or reproductive importance for patients or research participants. Since national or international guidelines have not been established, the authors discuss for Germany the current opinions about the management of incidental findings in clinical care and research. Arguments Following the German genetic diagnosis act ("Gendiagnostikgesetz", GenDG), it is mandatory to inform about the possibility of incidental findings. It is part of the informed consent which findings are communicated to the patient, taking the right not to know and the protection of minors into account. In the research context, the GenDG is not valid; however, the disclosure of possible incidental findings should be also included in the consent documents. There is agreement that results of high clinical utility should be returned to participants, even if there is no obligation to do so. The following aspects have to be considered when dealing with incidental findings: (1) information given in the consent documents, (2) interpretation of genetic results according to high, moderate, possible, questionable or unknown clinical meaning, (3) processing of returning results at the present and in the future, and (4) decision about resources to evaluate the clinical utility, to communicate results and to transfer them into clinical practice. Conclusion There is urgent need for empirical research and policy development in the context of incidental genetic results. In addition, it is important to study how patients and participants understand and utilize incidental findings and to develop educative and communicative strategies.
Schlagwörter
- Ethics of clinical care and research, Genome analysis, German genetic diagnosis act, Incidental findings
ASJC Scopus Sachgebiete
- Pflege (insg.)
- Probleme, Ethik und rechtliche Aspekte
- Sozialwissenschaften (insg.)
- Gesundheit (Sozialwissenschaften)
- Geisteswissenschaftliche Fächer (insg.)
- Philosophie
- Medizin (insg.)
- Health policy
Ziele für nachhaltige Entwicklung
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Ethik in der Medizin, Jahrgang 26, Nr. 2, 06.2014, S. 105-119.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Ethische und rechtliche Aspekte im Umgang mit genetischen Zufallsbefunden - Herausforderungen und Lösungsansätze
AU - Rudnik-Schöneborn, Sabine
AU - Langanke, Martin
AU - Erdmann, Pia
AU - Robienski, Jürgen
PY - 2014/6
Y1 - 2014/6
N2 - Definition of the problem With an increasing number of genetic results obtained in whole genome analyses, the problem of incidental findings arises, i.e., findings that are discovered beyond the aims of the original investigation but have potential health or reproductive importance for patients or research participants. Since national or international guidelines have not been established, the authors discuss for Germany the current opinions about the management of incidental findings in clinical care and research. Arguments Following the German genetic diagnosis act ("Gendiagnostikgesetz", GenDG), it is mandatory to inform about the possibility of incidental findings. It is part of the informed consent which findings are communicated to the patient, taking the right not to know and the protection of minors into account. In the research context, the GenDG is not valid; however, the disclosure of possible incidental findings should be also included in the consent documents. There is agreement that results of high clinical utility should be returned to participants, even if there is no obligation to do so. The following aspects have to be considered when dealing with incidental findings: (1) information given in the consent documents, (2) interpretation of genetic results according to high, moderate, possible, questionable or unknown clinical meaning, (3) processing of returning results at the present and in the future, and (4) decision about resources to evaluate the clinical utility, to communicate results and to transfer them into clinical practice. Conclusion There is urgent need for empirical research and policy development in the context of incidental genetic results. In addition, it is important to study how patients and participants understand and utilize incidental findings and to develop educative and communicative strategies.
AB - Definition of the problem With an increasing number of genetic results obtained in whole genome analyses, the problem of incidental findings arises, i.e., findings that are discovered beyond the aims of the original investigation but have potential health or reproductive importance for patients or research participants. Since national or international guidelines have not been established, the authors discuss for Germany the current opinions about the management of incidental findings in clinical care and research. Arguments Following the German genetic diagnosis act ("Gendiagnostikgesetz", GenDG), it is mandatory to inform about the possibility of incidental findings. It is part of the informed consent which findings are communicated to the patient, taking the right not to know and the protection of minors into account. In the research context, the GenDG is not valid; however, the disclosure of possible incidental findings should be also included in the consent documents. There is agreement that results of high clinical utility should be returned to participants, even if there is no obligation to do so. The following aspects have to be considered when dealing with incidental findings: (1) information given in the consent documents, (2) interpretation of genetic results according to high, moderate, possible, questionable or unknown clinical meaning, (3) processing of returning results at the present and in the future, and (4) decision about resources to evaluate the clinical utility, to communicate results and to transfer them into clinical practice. Conclusion There is urgent need for empirical research and policy development in the context of incidental genetic results. In addition, it is important to study how patients and participants understand and utilize incidental findings and to develop educative and communicative strategies.
KW - Ethics of clinical care and research
KW - Genome analysis
KW - German genetic diagnosis act
KW - Incidental findings
UR - http://www.scopus.com/inward/record.url?scp=84901253165&partnerID=8YFLogxK
U2 - 10.1007/s00481-013-0244-x
DO - 10.1007/s00481-013-0244-x
M3 - Artikel
AN - SCOPUS:84901253165
VL - 26
SP - 105
EP - 119
JO - Ethik in der Medizin
JF - Ethik in der Medizin
SN - 0935-7335
IS - 2
ER -